Abstract
Southern Africa is the region worst affected by HIV in the world and accounts for one third of the global burden of HIV. Achieving the UNAIDS 90-90-90 target by 2020 and ending the AIDS epidemic by 2030 depend on success in this region. We review epidemiological trends in each country in southern Africa with respect to the prevalence, incidence, mortality, coverage of anti-retroviral therapy (ART) and TB notification rates, to better understand progress in controlling HIV and TB and to determine what needs to be done to reach the UNAIDS targets. Significant progress has been made in controlling HIV. In all countries in the region, the prevalence of HIV in people not on ART, the incidence of HIV, AIDS-related mortality and, in most countries, TB notification rates, are falling. In some countries, the risk of infection began to fall before biomedical interventions such as ART became widely available as a result of effective prevention measures or people’s awareness of, and response to, the epidemic but the reasons for these declines remain uncertain. Some countries have achieved better levels of ART coverage than others, but all are in a position to reach the 2020 and 2030 targets if they accelerate the roll-out of ART and of targeted prevention efforts. Achieving the HIV treatment targets will further reduce the incidence of HIV-related TB, but efforts to control TB in HIV-negative people must be improved and strengthened.
Similar content being viewed by others
References
Papers of particular interest, published recently, have been highlighted as: • Of importance
UNAIDS. The Gap Report. Geneva: United Nations Joint Programme on HIV/AIDS. Available from: http://www.unaids.org/en/resources/documents/2014/20140716_UNAIDS_gap_report (2014).
UNAIDS. Ambitious treatment targets: writing the final chapter of the AIDS epidemic. Geneva: United Nations Joint Programme on HIV/AIDS. Available from: http://www.unaids.org/en/media/unaids/contentassets/documents/unaidspublication/2014/JC2670_UNAIDS_Treatment_Targets_en.pdf (2014). This documents sets and defines the UNAIDS targets for 2020 and 2030.
Department of International Economic and Social Affairs. World demographic estimates and projections, 1950–2025 United Nations, New York 1988.
Williams BG. Responding to the AIDS epidemic in Angola. arXiv. Electronic version: http://arxiv.org/pdf/1401.6430v1 (2014).
Williams BG. Optimizing control of HIV in Kenya. arXiv. Electronic version: http://arxiv.org/abs/1407.7801 (2014).
Williams BG. Managing HIV/AIDS in Malawi. arXiv. Electronic version: http://arxiv.org/abs/1409.4628 (2014).
Williams BG. Elimination of HIV in South Africa through expanded access to antiretroviral therapy: cautions, caveats and the importance of parsimony. arXiv. Electronic version: http://arxiv.org/pdf/1403.7104 (2014).
Williams BG. Fitting and projecting HIV epidemics: data, structure and parsimony. arXiv. Electronic version: http://arxiv.org/abs/1304.3720 (2014).
Williams BG, Granich R, De Cock K, Glaziou P, Sharma A, Dye C. Anti-retroviral therapy for the control of HIV-associated tuberculosis: modelling the potential effects in nine African countries. Proc Natl Acad Sci U S A. 2010;107:17853–4.
WHO. Global tuberculosis control: surveillance, planning, financing. Geneva: World Health Organization; 2014. Available from: http://apps.who.int/iris/bitstream/10665/137094/1/9789241564809_eng.pdf?ua=1.
Stover J, Brown T, Marston M. Updates to the Spectrum/Estimation and Projection Package (EPP) model to estimate HIV trends for adults and children. Sex Transm Infect. 2012;88 Suppl 2:i11–6.
Awad SF, Abu-Raddad LJ. Could there have been substantial declines in sexual risk behavior across sub-Saharan Africa in the mid-1990s? Epidemics. 2014;8:9–17. A similar analysis but with fewer countries and output variables.
Halperin DT, Mugurungi O, Hallett TB, Muchini B, Campbell B, Magure T, et al. A surprising prevention success: why did the HIV epidemic decline in Zimbabwe? PLoS Med. 2011;8, e1000414.
Hargrove JW, Humphrey JH, Mahomva A, Williams BG, Chidawanyika H, Mutasa K, et al. Declining HIV prevalence and incidence in perinatal women in Harare, Zimbabwe. Epidemics. 2011;3:88–94.
Gregson S, Gonese E, Hallett TB, Taruberekera N, Hargrove JW, Lopman B, et al. HIV decline in Zimbabwe due to reductions in risky sex? Evidence from a comprehensive epidemiological review. Int J Epidemiol. 2010;39:1311–23. Attempt to explain the decline in the epidemic of HIV in Zimbabwe.
Robb M. RV217: The early capture HIV cohort study (ECHO). Prospective identification of HIV infection prior to acute viraemia among high-risk populations. Poster Abstract 404. Presented at the Keystone Symposium. Whistler, British Columbia, Canada (2011).
Robb M. Viral dynamics and immune response in acute infection and their impact on viral set-point. In: Plenary session 02: a new look at the transmission event AIDS 2012 vaccine; Boston, 9–12 September 2012.
Abdool Karim SS, Naidoo K, Grobler A, Padayatchi N, Baxter C, Gray AL, et al. Integration of antiretroviral therapy with tuberculosis treatment. N Engl J Med. 2011;365:1492–501.
Harington JS, McGlashan ND, Chelkowska EZ. A century of migrant labour in the gold mines of South Africa. J S Afr Inst Min Metall. 2004; 65–71.
Brink B, Clausen L. The acquired immune deficiency syndrome. J Mine Med Off Assoc. 1987;63:10–7.
James WG. Our precious metal: African labour in South Africa’s gold industry, 1970–1990. Cape Town: David Philip; 1992.
Crush J, Jeeves A, Yudelman D. South Africa’s labour empire: a history of black migrancy to the gold mines. Boulder: Westview Press; 1991.
Maja, B. Towards a fairer deal for migrants in the South African Economy, Labour Market Review, Department of Labour, Republic of South Africa; 2007
Demographics of Swaziland. Available from: http://en.wikipedia.org/wiki/Demographics_of_Swaziland#Population_2.
Williams BG, MacPhail C, Campbell C, Taljaard D, Gouws E, Moema S, et al. The Carletonville-Mothusimpilo project: limiting transmission of HIV through community-based interventions. S Afr J Sci. 2000;96:351–9.
Williams BG, Gouws E. The epidemiology of human immunodeficiency virus in South Africa. Philos Trans R Soc Lond Ser B Biol Sci. 2001;356:1077–86.
Lurie MN, Williams BG, Zuma K, Mkaya-Mwamburi D, Garnett G, Sturm AW, et al. The impact of migration on HIV-1 transmission in South Africa: a study of migrant and nonmigrant men and their partners. Sex Transm Dis. 2003;30:149–56.
Lurie MN, Williams BG. Migration and health in Southern Africa: 100 years and still circulating. Health Psychol Behav Med. 2014;2(1):34–40. Discussion of the role of migration in the spread of HIV in southern Africa.
Williams BG, Gouws E, Lurie M, Crush J. Spaces of vulnerability: migration and HIV/AIDS in South Africa. 2002; Southern African migration project: migration policy series No 24. Cape Town: Queens University; 2002. Available from: Southern Africa Migration Project http://www.queensu.ca/samp/sampresources/samppublications/policyseries/Acrobat24.pdf
Hallett TB, Gregson S, Mugurungi O, Gonese E, Garnett GP. Assessing evidence for behaviour change affecting the course of HIV epidemics: a new mathematical modelling approach and application to data from Zimbabwe. Epidemics. 2009;1:108–17.
Alistar SS, Grant PM, Bendavid E. Comparative effectiveness and cost-effectiveness of antiretroviral therapy and pre-exposure prophylaxis for HIV prevention in South Africa. BMC Med. 2014;12:46.
Cohen B, Trussell J (Editors) Preventing and mitigating AIDS in Sub-Saharan Africa: research and data priorities for the social and behavioral sciences (Washington, DC) (1996).
Auvert B, Marseille E, Korenromp EL, Lloyd-Smith J, Sitta R, Taljaard D, et al. Estimating the resources needed and savings anticipated from roll-out of adult male circumcision in Sub-Saharan Africa. PLoS One. 2008;3, e2679.
Batist E, Brown B, Scheibe A, Baral SD, Bekker LG. Outcomes of a community-based HIV-prevention pilot programme for township men who have sex with men in Cape Town, South Africa. J Int AIDS Soc. 2013;16 Suppl 3:18754.
Williams BG, Granich R, Chauhan LS, Dharmshaktu NS, Dye C. The impact of HIV/AIDS on the control of tuberculosis in India. Proc Natl Acad Sci U S A. 2005;102:9619–24.
WHO. A brief history of tuberculosis control in Kenya. Geneva: World Health Organization; 2009. Available from: http://whqlibdoc.who.int/publications/2009/9789241596923_eng.pdf.
Larmarange J, Bendaud V. HIV estimates at second subnational level from national population-based surveys. AIDS. 2014;28 Suppl 4:S469–76.
Anonymous. National Antenatal Sentinel HIV and Syphilis Prevalence Survey in South Africa, 2012. Department of Health, South Africa. Available from: www.doh.gov.za (2012).
Kassanjee R, Pilcher CD, Keating SM, Facente SN, McKinney E, Price MA, et al. Independent assessment of candidate HIV incidence assays on specimens in the CEPHIA repository. AIDS. 2014;28:2439–49.
Kim AA, Hallett T, Stover J, Gouws E, Musinguzi J, Mureithi PK, et al. Estimating HIV incidence among adults in Kenya and Uganda: a systematic comparison of multiple methods. PLoS One. 2011;6, e17535.
Malawi Department of Health. Integrated HIV Program Report: October – December. Blantyre: Ministry of Health, Malawi. Available from: http://www.hivunitmohmw.org/uploads/Main/Quarterly_HIV_Programme_Report_2012_Q4.pdf (2012). Patient monitoring in Malawi.
UNAIDS. Regional consultation to set new targets for the HIV response post-2015 in Eastern and Southern Africa. Johannesburg; 19–20 May 2014. Available from: www.unaidsrstesa.org (2014).
Williams BG, Korenromp EL, Gouws E, Schmid GP, Auvert B, Dye C. HIV Infection, antiretroviral therapy, and CD4+ cell count distributions in African populations. J Infect Dis. 2006;194:1450–8.
The Ministry of Health and Ministry of Community Development MaCH. Zambia consolidated guidelines for treatment and prevention of HIV infection. Lusaka. Available from: https://xa.yimg.com/…/Zambia+HIV+Consolidated+Guidelines+−+Feb+2014+Version+−final+draft-3 (2014).
Ministerio da Saude SNdS. Relatório Semestral das Actividades Relacionadas ao HIV/SIDA. Moçambique. 2014. Maputo.
Maman D. Chiradzulu HIV impact population survey. Ministry of Health of Malawi, Médecin Sans Frontières; 2013. Available from: http://www.epicentre.msf.org.
Deeks SG, Autran B, Berkhout B, Benkirane M, Cairns S, Chomont N, et al. Towards an HIV cure: a global scientific strategy. Nat Rev Immunol. 2012;12:607–14.
Gras L, Kesselring AM, Griffin JT, van Sighem AI, Fraser C, Ghani AC, et al. CD4 cell counts of 800 cells/mm3 or greater after 7 years of highly active antiretroviral therapy are feasible in most patients starting with 350 cells/mm3 or greater. J Acquir Immune Defic Syndr Hum Retrovirol. 2007;45:183–92.
Antoniou T, Gillis J, Loutfy MR, Cooper C, Hogg RS, Klein MB, et al. Impact of the data collection on adverse events of anti-HIV drugs cohort study on abacavir prescription among treatment-naive, HIV-infected patients in Canada. J Int Assoc Provid AIDS Care. 2014;13:153–9.
Williams BG, Maher D. Tuberculosis fuelled by HIV: putting out the flames. Am J Respir Crit Care Med. 2007;175:6–8.
UNAIDS. Fast-track: ending the AIDS epidemic by 2030. Geneva: United Nations Joint Programme on HIV/AIDS; 2014. Available from: http://www.unaids.org/sites/default/files/media_asset/JC2686_WAD2014report_en.pdf.
PEPFAR 3.0: Controlling the epidemic: delivering on the promise of an AIDS-free Generation. Available at http://www.pepfar.gov/documents/organization/234744.pdf.
Disclaimer
The findings and conclusions in this paper are those of the authors and do not necessarily represent the views of UNAIDS.
Compliance with Ethics Guidelines
ᅟ
Conflict of Interest
Brian G. Williams, Eleanor Gouws, Pierre Somse, Mpho Mmelesi, Chibwe Lwamba, Trouble Chikoko, Erika Fazito, Mohamed Turay, Eva Kiwango, Pepukai Chikukwa, Henry Damisoni and Michael Gboun declare that they have no conflict of interest.
Human and Animal Rights and Informed Consent
This article does not contain any studies with human or animal subjects performed by any of the authors.
Author information
Authors and Affiliations
Corresponding author
Additional information
This article is part of the Topical Collection on The Global Epidemic
Electronic Supplementary Material
Below is the link to the electronic supplementary material.
ESM 1
(DOC 15285 kb)
Rights and permissions
About this article
Cite this article
Williams, B.G., Gouws, E., Somse, P. et al. Epidemiological Trends for HIV in Southern Africa: Implications for Reaching the Elimination Targets. Curr HIV/AIDS Rep 12, 196–206 (2015). https://doi.org/10.1007/s11904-015-0264-x
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11904-015-0264-x